ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Neurology

Top Neurology Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARINA NEYSTAT M.D.

Neurology

7,911

$1.33M

750
624 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 29%

$168
Average prescription price

Avg: $234

KOOROSH DAWOODI MD

Neurology

7,564

$403K

331
302 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 29%

$53
Average prescription price

Avg: $234

DMITRIY GRINSHPUN M.D.

Neurology

6,374

$746K

608
475 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 29%

$117
Average prescription price

Avg: $234

CASILDA BALMACEDA M.D.

Neurology

6,360

$2.12M

614
415 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 29%

$333
Average prescription price

Avg: $234

KENNETH MURRAY M.D.

Neurology

6,341

$1.42M

465
160 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 29%

$224
Average prescription price

Avg: $234

SOWBHAGYA SONTHINENI M.D.

Neurology

6,264

$1.48M

420
197 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 29%

$237
Average prescription price

Avg: $234

OTHONIEL CASTRO MD

Neurology

5,812

$1.57M

745
502 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 29%

$270
Average prescription price

Avg: $234

LORENZA FREDDO M.D.

Neurology

5,751

$1.09M

481
239 are 65+

37%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 29%

$189
Average prescription price

Avg: $234

GREGORY SEEGER MD

Neurology

5,587

$1.04M

445
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 2%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 29%

$186
Average prescription price

Avg: $234

JESS COLLINS M.D.

Neurology

5,572

$995K

347
59 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 29%

$178
Average prescription price

Avg: $234

EUGENE GOSY

Neurology

5,511

$860K

1210
477 are 65+

61%
patients receiving schedule two controlled substances

Avg: 3%

38%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 29%

$156
Average prescription price

Avg: $234

ENRICO FAZZINI DO

Neurology

5,449

$985K

351
285 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 29%

$181
Average prescription price

Avg: $234

ROBERT KNAPP MD

Neurology

5,262

$711K

466
260 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 29%

$135
Average prescription price

Avg: $234

XIAO-KE GAO M.D.

Neurology

4,893

$576K

717
551 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 29%

$118
Average prescription price

Avg: $234

TERESELLA GONDOLO MD

Neurology

4,832

$343K

705
502 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 29%

$71
Average prescription price

Avg: $234

ROSSELLA CAVALIERE M.D.

Neurology

4,765

$1.93M

299
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 29%

$405
Average prescription price

Avg: $234

ALAN MAZUREK MD

Neurology

4,718

$1.07M

474
418 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 29%

$227
Average prescription price

Avg: $234

EUGENE PAK M.D.

Neurology

4,600

$387K

613
367 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

34%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 29%

$84
Average prescription price

Avg: $234

JOSEPH JERET MD

Neurology

4,576

$1.07M

382
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 29%

$234
Average prescription price

Avg: $234

LUCIEN COTE M.D.

Neurology

4,525

$478K

281
268 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 29%

$106
Average prescription price

Avg: $234

ANDREW HILBURGER M.D.

Neurology

4,521

$838K

425
227 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 29%

$185
Average prescription price

Avg: $234

MIRZA BEG MD

Neurology

4,470

$223K

193
142 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 29%

$50
Average prescription price

Avg: $234

ELVIRA KAMENETSKY M.D.

Neurology

4,464

$616K

510
466 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

54%
prescriptions for brand name drugs

Avg: 29%

$138
Average prescription price

Avg: $234

MIRAN SALGADO MD

Neurology

4,453

$1.14M

340
281 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 29%

$257
Average prescription price

Avg: $234

SANA BLOCH MD

Neurology

4,362

$819K

647
411 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 29%

$188
Average prescription price

Avg: $234

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank